E3 ubiquitin ligase RBCK1 confers ferroptosis resistance in pancreatic cancer by facilitating MFN2 degradation
Authors:
- 18 May 2024
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 221, 136-154
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Mfn2-mediated mitochondrial fusion promotes autophagy and suppresses ovarian cancer progression by reducing ROS through AMPK/mTOR/ERK signalingCellular and Molecular Life Sciences, 2022
- Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1Cell Metabolism, 2021
- Efficacy of Perioperative Chemotherapy for Resectable Pancreatic AdenocarcinomaJAMA Oncology, 2021
- Therapeutic potential of targeting mitochondrial dynamics in cancerBiochemical Pharmacology, 2020
- Ferroptosis mediated by the interaction between Mfn2 and IREα promotes arsenic-induced nonalcoholic steatohepatitisEnvironmental Research, 2020
- Targeting Ferroptosis to Iron Out CancerCancer Cell, 2019
- Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma ModelCell Chemical Biology, 2019
- Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancerCancer Letters, 2016
- Gemcitabine resistance in pancreatic ductal adenocarcinomaDrug Resistance Updates, 2015
- Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cellsCancer, 2000